• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Relevance of comorbidities for main outcomes during different periods of the COVID-19 pandemic

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Jan 16;18(1):e13240.
doi: 10.1111/irv.13240. eCollection 2024 Jan. Relevance of comorbidities for main outcomes during different periods of the COVID-19 pandemic

José M Quintana-Lopez[SUP] 1 2 3 4 [/SUP], Lander Rodríguez[SUP] 5 [/SUP], Janire Portuondo[SUP] 2 6 7 [/SUP], Julia García[SUP] 8 [/SUP], Maria Jose Legarreta[SUP] 1 2 3 4 [/SUP], María Gascón[SUP] 1 2 3 4 [/SUP], Nere Larrea[SUP] 1 2 3 4 [/SUP], Irantzu Barrio[SUP] 5 9 [/SUP]; COVID‐Health Basque Country Research Group



Collaborators, Affiliations
Free PMC article Abstract

Background: Throughout the evolution of the COVID-19 pandemic, the severity of the disease has varied. The aim of this study was to determine how patients' comorbidities affected and were related to, different outcomes during this time.
Methods: Retrospective cohort study of all patients testing positive for SARS-CoV-2 infection between March 1, 2020, and January 9, 2022. We extracted sociodemographic, basal comorbidities, prescribed treatments, COVID-19 vaccination data, and outcomes such as death and admission to hospital and intensive care unit (ICU) during the different periods of the pandemic. We used logistic regression to quantify the effect of each covariate in each outcome variable and a random forest algorithm to select the most relevant comorbidities.
Results: Predictors of death included having dementia, heart failure, kidney disease, or cancer, while arterial hypertension, diabetes, ischemic heart, cerebrovascular, peripheral vascular diseases, and leukemia were also relevant. Heart failure, dementia, kidney disease, diabetes, and cancer were predictors of adverse evolution (death or ICU admission) with arterial hypertension, ischemic heart, cerebrovascular, peripheral vascular diseases, and leukemia also relevant. Arterial hypertension, heart failure, diabetes, kidney, ischemic heart diseases, and cancer were predictors of hospitalization, while dyslipidemia and respiratory, cerebrovascular, and peripheral vascular diseases were also relevant.
Conclusions: Preexisting comorbidities such as dementia, cardiovascular and renal diseases, and cancers were those most related to adverse outcomes. Of particular note were the discrepancies between predictors of adverse outcomes and predictors of hospitalization and the fact that patients with dementia had a lower probability of being admitted in the first wave.

Keywords: COVID‐19; comorbidity; healthcare; outcome assessment; patient acuity.

 
Back
Top Bottom